A new trading day began on Monday, with Cassava Sciences Inc (NASDAQ: SAVA) stock price down -8.70% from the previous day of trading, before settling in for the closing price of $3.22. SAVA’s price has ranged from $2.78 to $42.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 62.79%. With a float of $41.79 million, this company’s outstanding shares have now reached $47.98 million.
The extent of productivity of a business whose workforce counts for 29 workers is very important to gauge. In terms of profitability, gross margin is 58.82%, operating margin of -5985.86%, and the pretax margin is -752.3%.
Cassava Sciences Inc (SAVA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cassava Sciences Inc is 13.14%, while institutional ownership is 29.68%. The most recent insider transaction that took place on Nov 29 ’24, was worth 15,480. In this transaction Chief Medical Officer of this company sold 4,000 shares at a rate of $3.87, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Chief Financial Officer sold 59,800 for $3.86, making the entire transaction worth $230,828. This insider now owns 11,500 shares in total.
Cassava Sciences Inc (SAVA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 62.79% per share during the next fiscal year.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Here are Cassava Sciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Cassava Sciences Inc (SAVA)
The latest stats from [Cassava Sciences Inc, SAVA] show that its last 5-days average volume of 7.51 million was superior to 2.58 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 10.40%. Additionally, its Average True Range was 2.32.
During the past 100 days, Cassava Sciences Inc’s (SAVA) raw stochastic average was set at 0.41%, which indicates a significant decrease from 0.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 738.94% in the past 14 days, which was higher than the 315.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.30, while its 200-day Moving Average is $21.96. Now, the first resistance to watch is $3.13. This is followed by the second major resistance level at $3.32. The third major resistance level sits at $3.42. If the price goes on to break the first support level at $2.84, it is likely to go to the next support level at $2.74. The third support level lies at $2.55 if the price breaches the second support level.
Cassava Sciences Inc (NASDAQ: SAVA) Key Stats
With a market capitalization of 148.84 million, the company has a total of 48,110K Shares Outstanding. Currently, annual sales are 0 K while annual income is -97,220 K. The company’s previous quarter sales were 0 K while its latest quarter income was -27,940 K.
